Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2011

01-08-2011 | Case Report

Morphological and functional analyses of two infants with obstructive renal dysplasia

Authors: Kenichiro Miura, Takashi Sekine, Riki Nishimura, Yutaka Kanamori, Atsuhiro Yanagisawa, Kiyohide Sakai, Michio Nagata, Takashi Igarashi

Published in: Clinical and Experimental Nephrology | Issue 4/2011

Login to get access

Abstract

Renal dysplasia associated with urinary tract obstruction comprises two distinct phenotypes, i.e., multicystic dysplastic kidney (MCDK) and obstructive renal dysplasia (ORD). MCDK is a common manifestation in infants with renal dysplasia, which is characterized by multiloculated thin-walled cysts with no functional parenchyma and an atretic ureter owing to pyelocalyceal occlusion early in fetal life. In contrast, ORD is an extremely rare condition which is caused by severe obstruction of the distal ureter or urethra. Here, we report two infants with ORD. Both patients manifested unilateral kidney enlargement with multiple cortical cysts, mild hydronephrosis, and marked dilatation of the ipsilateral ureter. Contralateral kidneys and urinary tracts revealed no apparent radiological abnormalities. Serial ultrasonographic studies of fetal and neonatal kidneys in both cases revealed that ureteral dilatation was evident at gestational week 16 and 27, respectively, and most of the cortical cysts disappeared within 1–3 months after birth. The functions of the affected kidneys were severely impaired but evident at the time of birth. These manifestations were consistent with a diagnosis of ORD, and were distinct from the features of MCDK. Our observation of fetal and infantile kidneys in these two cases provides us with a better understanding of the pathogenesis of ORD.
Literature
1.
go back to reference Bernstein J. Renal hypoplasia and dysplasia. In: Edelmann CM, editor. Pediatric kidney disease. 2nd ed. Boston: Little Brown; 1992. p. 1121–37. Bernstein J. Renal hypoplasia and dysplasia. In: Edelmann CM, editor. Pediatric kidney disease. 2nd ed. Boston: Little Brown; 1992. p. 1121–37.
2.
go back to reference Dillon E, Ryall A. A 10 year audit of antenatal ultrasound detection of renal disease. Br J Radiol. 1998;71:497–500.CrossRefPubMed Dillon E, Ryall A. A 10 year audit of antenatal ultrasound detection of renal disease. Br J Radiol. 1998;71:497–500.CrossRefPubMed
3.
go back to reference Bernstein J. Congenital malformations of the kidney. In: Tisher CC, editor. Renal pathology: with clinical and functional correlations. 2nd ed. Philadelphia: Lippincott; 1994. p. 1355–86. Bernstein J. Congenital malformations of the kidney. In: Tisher CC, editor. Renal pathology: with clinical and functional correlations. 2nd ed. Philadelphia: Lippincott; 1994. p. 1355–86.
4.
go back to reference Dell KM, Sweeney WE, Avner ED. Polycystic kidney disease. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. 6th ed. Heidelberg: Springer; 2009. p. 849–87.CrossRef Dell KM, Sweeney WE, Avner ED. Polycystic kidney disease. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. 6th ed. Heidelberg: Springer; 2009. p. 849–87.CrossRef
5.
go back to reference Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal cystic diseases: a review. Adv Anat Pathol. 2006;13:26–56.CrossRefPubMed Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal cystic diseases: a review. Adv Anat Pathol. 2006;13:26–56.CrossRefPubMed
6.
go back to reference Simoneaux SF, Greenbaum LA. Diagnostic imaging. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. 6th ed. Heidelberg: Springer; 2009. p. 535–64.CrossRef Simoneaux SF, Greenbaum LA. Diagnostic imaging. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. 6th ed. Heidelberg: Springer; 2009. p. 535–64.CrossRef
7.
go back to reference Nagata M, Shibata S, Shu Y. Pathogenesis of dysplastic kidney associated with urinary tract obstruction in utero. Nephrol Dial Transplant. 2002;17(Suppl 9):37–8.CrossRefPubMed Nagata M, Shibata S, Shu Y. Pathogenesis of dysplastic kidney associated with urinary tract obstruction in utero. Nephrol Dial Transplant. 2002;17(Suppl 9):37–8.CrossRefPubMed
8.
go back to reference Glassberg KI. Renal dysgenesis and cystic disease of the kidney. In: Wein AJ, editor. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 3305–58. Glassberg KI. Renal dysgenesis and cystic disease of the kidney. In: Wein AJ, editor. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 3305–58.
9.
go back to reference Terada S, Suzuki N, Uchida K, Ueno H, Akasofu K. Etiology of prune belly syndrome: evidence of megalocystic origin in an early fetus. Obstet Gynecol. 1994;83:865–8.PubMed Terada S, Suzuki N, Uchida K, Ueno H, Akasofu K. Etiology of prune belly syndrome: evidence of megalocystic origin in an early fetus. Obstet Gynecol. 1994;83:865–8.PubMed
10.
go back to reference Shigeta M, Nagata M, Shimoyamada H, Shibata S, Okuno S, Hamada H, et al. Prune-belly syndrome diagnosed at 14 weeks’ gestation with severe urethral obstruction but normal kidneys. Pediatr Nephrol. 1999;13:135–7.CrossRefPubMed Shigeta M, Nagata M, Shimoyamada H, Shibata S, Okuno S, Hamada H, et al. Prune-belly syndrome diagnosed at 14 weeks’ gestation with severe urethral obstruction but normal kidneys. Pediatr Nephrol. 1999;13:135–7.CrossRefPubMed
11.
12.
go back to reference Becker N, Avner ED. Congenital nephropathies and uropathies. Pediatr Nephrol. 1995;42:1319–41. Becker N, Avner ED. Congenital nephropathies and uropathies. Pediatr Nephrol. 1995;42:1319–41.
13.
go back to reference Shibata S, Shigeta M, Shu Y, Watanabe T, Nagata M. Initial pathological events in renal dysplasia with urinary tract obstruction in utero. Virchows Arch. 2001;439:560–70.CrossRefPubMed Shibata S, Shigeta M, Shu Y, Watanabe T, Nagata M. Initial pathological events in renal dysplasia with urinary tract obstruction in utero. Virchows Arch. 2001;439:560–70.CrossRefPubMed
14.
go back to reference Evans MI, Sacks AJ, Johnson MP, Robichaux AG 3rd, May M, Moghissi KS. Sequential invasive assessment of fetal renal function and the intrauterine treatment of fetal obstructive uropathies. Obstet Gynecol. 1991;77:545–50.PubMed Evans MI, Sacks AJ, Johnson MP, Robichaux AG 3rd, May M, Moghissi KS. Sequential invasive assessment of fetal renal function and the intrauterine treatment of fetal obstructive uropathies. Obstet Gynecol. 1991;77:545–50.PubMed
15.
go back to reference Kitagawa H, Pringle KC, Koike J, Zuccollo J, Seki Y, Wakisaka M, Sato Y, Nagae H, Nakada K. Vesicoamniotic shunt for complete urinary tract obstruction is partially effective. J Pediatr Surg. 2006;41:394–402.CrossRefPubMed Kitagawa H, Pringle KC, Koike J, Zuccollo J, Seki Y, Wakisaka M, Sato Y, Nagae H, Nakada K. Vesicoamniotic shunt for complete urinary tract obstruction is partially effective. J Pediatr Surg. 2006;41:394–402.CrossRefPubMed
Metadata
Title
Morphological and functional analyses of two infants with obstructive renal dysplasia
Authors
Kenichiro Miura
Takashi Sekine
Riki Nishimura
Yutaka Kanamori
Atsuhiro Yanagisawa
Kiyohide Sakai
Michio Nagata
Takashi Igarashi
Publication date
01-08-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0429-x

Other articles of this Issue 4/2011

Clinical and Experimental Nephrology 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine